These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 33645365)

  • 1. Targeting the TGF-β signaling pathway for fibrosis therapy: a patent review (2015-2020).
    Li X; Ding Z; Wu Z; Xu Y; Yao H; Lin K
    Expert Opin Ther Pat; 2021 Aug; 31(8):723-743. PubMed ID: 33645365
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting the TGF-β signaling pathway: an updated patent review (2021-present).
    Guo W; Liu H; Yan Y; Wu D; Yao H; Lin K; Li X
    Expert Opin Ther Pat; 2024 Mar; 34(3):99-126. PubMed ID: 38648107
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Organ fibrosis inhibited by blocking transforming growth factor-β signaling via peroxisome proliferator-activated receptor γ agonists.
    Deng YL; Xiong XZ; Cheng NS
    Hepatobiliary Pancreat Dis Int; 2012 Oct; 11(5):467-78. PubMed ID: 23060391
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting TGF-β signaling for the treatment of fibrosis.
    Györfi AH; Matei AE; Distler JHW
    Matrix Biol; 2018 Aug; 68-69():8-27. PubMed ID: 29355590
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting TGF-β Signaling in Kidney Fibrosis.
    Isaka Y
    Int J Mol Sci; 2018 Aug; 19(9):. PubMed ID: 30150520
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oral pirfenidone protects against fibrosis by inhibiting fibroblast proliferation and TGF-β signaling in a murine colitis model.
    Li G; Ren J; Hu Q; Deng Y; Chen G; Guo K; Li R; Li Y; Wu L; Wang G; Gu G; Li J
    Biochem Pharmacol; 2016 Oct; 117():57-67. PubMed ID: 27498142
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Noncanonical transforming growth factor beta signaling in scleroderma fibrosis.
    Trojanowska M
    Curr Opin Rheumatol; 2009 Nov; 21(6):623-9. PubMed ID: 19713852
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Blockade of TGF-β/Smad signaling by the small compound HPH-15 ameliorates experimental skin fibrosis.
    Luong VH; Chino T; Oyama N; Matsushita T; Sasaki Y; Ogura D; Niwa SI; Biswas T; Hamasaki A; Fujita M; Okamoto Y; Otsuka M; Ihn H; Hasegawa M
    Arthritis Res Ther; 2018 Mar; 20(1):46. PubMed ID: 29544542
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Strategies for TGF-beta modulation: a review of recent patents.
    Bonafoux D; Lee WC
    Expert Opin Ther Pat; 2009 Dec; 19(12):1759-69. PubMed ID: 19939191
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TGF-β-induced fibrosis: A review on the underlying mechanism and potential therapeutic strategies.
    Ong CH; Tham CL; Harith HH; Firdaus N; Israf DA
    Eur J Pharmacol; 2021 Nov; 911():174510. PubMed ID: 34560077
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of small molecule inhibitors targeting TGF-β ligand and receptor: Structures, mechanism, preclinical studies and clinical usage.
    Wang H; Chen M; Sang X; You X; Wang Y; Paterson IC; Hong W; Yang X
    Eur J Med Chem; 2020 Apr; 191():112154. PubMed ID: 32092587
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TGF-β signaling in the kidney: profibrotic and protective effects.
    Sureshbabu A; Muhsin SA; Choi ME
    Am J Physiol Renal Physiol; 2016 Apr; 310(7):F596-F606. PubMed ID: 26739888
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antitransforming growth factor-beta therapy in fibrosis: recent progress and implications for systemic sclerosis.
    Varga J; Pasche B
    Curr Opin Rheumatol; 2008 Nov; 20(6):720-8. PubMed ID: 18946334
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HuangQi Decoction Ameliorates Renal Fibrosis via TGF-β/Smad Signaling Pathway In Vivo and In Vitro.
    Zhao J; Wang L; Cao AL; Jiang MQ; Chen X; Wang Y; Wang YM; Wang H; Zhang XM; Peng W
    Cell Physiol Biochem; 2016; 38(5):1761-74. PubMed ID: 27161221
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glucosamine hydrochloride exerts a protective effect against unilateral ureteral obstruction-induced renal fibrosis by attenuating TGF-β signaling.
    Park J; Lee SY; Ooshima A; Yang KM; Kang JM; Kim YW; Kim SJ
    J Mol Med (Berl); 2013 Nov; 91(11):1273-84. PubMed ID: 24072041
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Murine Precision-cut Intestinal Slices as a Potential Screening Tool for Antifibrotic Drugs.
    Iswandana R; Pham BT; Suriguga S; Luangmonkong T; van Wijk LA; Jansen YJM; Oosterhuis D; Mutsaers HAM; Olinga P
    Inflamm Bowel Dis; 2020 Apr; 26(5):678-686. PubMed ID: 31943022
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting the LPA1 signaling pathway for fibrosis therapy: a patent review (2010-present).
    Gu Z; Yan Y; Yao H; Lin K; Li X
    Expert Opin Ther Pat; 2022 Oct; 32(10):1097-1122. PubMed ID: 36175357
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Schisandrin B attenuates CCl
    Chen Q; Zhang H; Cao Y; Li Y; Sun S; Zhang J; Zhang G
    Drug Des Devel Ther; 2017; 11():2179-2191. PubMed ID: 28794616
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modifiers of TGF-β1 effector function as novel therapeutic targets of pulmonary fibrosis.
    Lee CM; Park JW; Cho WK; Zhou Y; Han B; Yoon PO; Chae J; Elias JA; Lee CG
    Korean J Intern Med; 2014 May; 29(3):281-90. PubMed ID: 24851060
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evogliptin attenuates bleomycin-induced lung fibrosis via inhibiting TGF-β/Smad signaling in fibroblast.
    Ba YD; Sun JH; Zhao XX
    Eur Rev Med Pharmacol Sci; 2020 Oct; 24(20):10790-10798. PubMed ID: 33155239
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.